Resource Type

Journal Article 189

Conference Videos 1

Year

2024 2

2023 31

2022 27

2021 17

2020 7

2019 11

2018 13

2017 11

2016 6

2015 3

2014 4

2013 5

2012 10

2011 4

2010 8

2009 13

2008 4

2007 7

2001 1

1999 1

open ︾

Keywords

tumor 4

Adsorption 3

Biochar 3

metastasis 3

CO2 adsorption 2

Colorectal cancer 2

Exosomes 2

PD-L1 2

Tumor 2

angiogenesis 2

biomass-derived carbon 2

cancer therapy 2

esterification 2

hepatocellular carcinoma 2

immune checkpoint inhibitor 2

immunotherapy 2

tumor immunotherapy 2

tumor microenvironment 2

2-methoxyethylenoxy 1

open ︾

Search scope:

排序： Display mode:

Tumor-Specific CircRNA-Derived Antigen Peptide Identification for Hepatobiliary Tumors Article

Wenwen Wang, Lili Ma, Zheng Xing, Tinggan Yuan, Jinxia Bao, Yanjing Zhu, Xiaofang Zhao, Yan Zhao, Yali Zong, Yani Zhang, Siyun Shen, Xinyao Qiu, Shuai Yang, Hongyang Wang, Dong Gao, Peng Wang, Lei Chen

Engineering 2023, Volume 22, Issue 3,   Pages 159-170 doi: 10.1016/j.eng.2022.06.008

Abstract: antigen peptides in hepatobiliary tumor organoids.CircRNA-derived tumor-specific peptides presented by the HLA-ABC molecules stimulated cluster of differentiationCytotoxic T cell activity targeting the organoids, induced by the immunogenic circRNA-derived peptidesorganoid survival rate.tumor-specific circRNAs in cancers.

Keywords： Tumor antigen     Patient-derived hepatobiliary tumor organoid     Circular RNA     Mass-spectrometry-based immunopeptidomics    

HTML PDF Collect

Patient-derived xenograft platform of OSCC: a renewable human bio-bank for preclinical cancer research

Shuyang Sun,Zhiyuan Zhang

Frontiers of Medicine 2016, Volume 10, Issue 1,   Pages 104-110 doi: 10.1007/s11684-016-0432-4

Abstract: Patient-derived xenograft (PDX) models generated from human tumor samples that can retain the histologicalRecently, we have successfully established and characterized an OSCC PDX panel as part of our tumor bio-bankthe translational value of this well-annotated PDX panel in the development of co-clinical trials for patient

Keywords： patient-derived xenograft models     personalized medicine     co-clinical trial     patient stratification     oral    

HTML PDF Collect

Repurposed benzydamine targeting CDK2 suppresses the growth of esophageal squamous cell carcinoma

Frontiers of Medicine 2023, Volume 17, Issue 2,   Pages 290-303 doi: 10.1007/s11684-022-0956-8

Abstract: Esophageal squamous cell carcinoma (ESCC) is one of the leading causes of cancer death worldwide. It is urgent to develop new drugs to improve the prognosis of ESCC patients. Here, we found benzydamine, a locally acting non-steroidal anti-inflammatory drug, had potent cytotoxic effect on ESCC cells. Benzydamine could suppress ESCC proliferation in vivo and in vitro. In terms of mechanism, CDK2 was identified as a target of benzydamine by molecular docking, pull-down assay and in vitro kinase assay. Specifically, benzydamine inhibited the growth of ESCC cells by inhibiting CDK2 activity and affecting downstream phosphorylation of MCM2, c-Myc and Rb, resulting in cell cycle arrest. Our study illustrates that benzydamine inhibits the growth of ESCC cells by downregulating the CDK2 pathway.

Keywords： benzydamine     cyclin-dependent kinase 2     patient-derived xenograft     esophageal squamous cell carcinoma    

HTML PDF Collect

Prediction of Driver Gene Matching in Lung Cancer NOG/PDX Models Based on Artificial Intelligence Article

Yayi He, Haoyue Guo, Li Diao, Yu Chen, Junjie Zhu, Hiran C. Fernando, Diego Gonzalez Rivas, Hui Qi, Chunlei Dai, Xuzhen Tang, Jun Zhu, Jiawei Dai, Kan He, Dan Chan, Yang Yang

Engineering 2022, Volume 15, Issue 8,   Pages 102-114 doi: 10.1016/j.eng.2021.06.017

Abstract:

Patient-derived tumor xenografts (PDXs) are a powerful tool for drug discovery and screening in cancer

Keywords： Machine learning     Patient-derived tumor xenografts     NOG mice    

HTML PDF Collect

The value of radionuclide hepatobiliary scintigraphy in combination with determination of bilirubin from

Sheng-Xuan LIU, Zhi-Hua HUANG

Frontiers of Medicine 2010, Volume 4, Issue 3,   Pages 342-345 doi: 10.1007/s11684-010-0099-1

Abstract: The aim of this study was to investigate the value of technetium etifenin injection ( Tc-EHIDA) hepatobiliaryTc-EHIDA hepatobiliary scintigraphy in combination with duodenal fluid examination was used for evaluationIn conclusion, hepatobiliary scintigraphy, which is a noninvasive, safe, valuable examination method,

Keywords： jaundice     radionuclide hepatobiliary scintigraphy     duodenal drainage    

HTML PDF Collect

Tumor-derived exosomes induce initial activation by exosomal CD19 antigen but impair the function of

Frontiers of Medicine doi: 10.1007/s11684-023-1010-1

Abstract: Tumor-derived exosomes induce initial activation by exosomal CD19 antigen but impair the function of

Keywords： exosomes induce activation     impair function CD19     exosomal CD19 antigen    

HTML PDF Collect

Organoid Technology and Clinical Applications in Digestive System Cancer Review

Xiaofang Zhao, Youhai Jiang, Chunliang Liu, Minghui Hou, Hongyang Wang, Jing Fu

Engineering 2022, Volume 9, Issue 2,   Pages 123-130 doi: 10.1016/j.eng.2021.04.017

Abstract: Current cancer models cannot faithfully recapitulate the critical features of the original tumor, resultingOrganoids are in vitro cultured three dimensional (3D) self-organizing organotypic structures derived

Keywords： Organoid     Digestive system cancer     Precision medicine    

HTML PDF Collect

Arsenic trioxide induced rhabdomyolysis, a rare but severe side effect, in an APL patient: a case report

Haiyan He, Ran An, Jian Hou, Weijun Fu

Frontiers of Medicine 2017, Volume 11, Issue 2,   Pages 284-286 doi: 10.1007/s11684-017-0514-y

Abstract: In this report, we present a rare side effect, rhabdomyolysis, in a 68-year-old female APL patient who

Keywords： arsenic trioxide     APL     rhabdomyolysis    

HTML PDF Collect

Heterogeneity of the tumor immune microenvironment and clinical interventions

Frontiers of Medicine 2023, Volume 17, Issue 4,   Pages 617-648 doi: 10.1007/s11684-023-1015-9

Abstract: Heterogeneity of the tumor immune microenvironment and clinical interventions

Keywords： Heterogeneity tumor immune    

HTML PDF Collect

Proteins moonlighting in tumor metabolism and epigenetics

Lei Lv, Qunying Lei

Frontiers of Medicine 2021, Volume 15, Issue 3,   Pages 383-403 doi: 10.1007/s11684-020-0818-1

Abstract: interplay of multiple signaling pathways and restrained by oxygen and nutrient accessibility in the tumorThe signal−moonlighting protein−metabolism axis facilitates the adaptation of tumor cells under varying

Keywords： moonlighting function     tumor metabolism     epigenetics    

HTML PDF Collect

An investigation on patient dose in screen-film diagnostic radiology in Lhasa City, Xizang Autonomous

Xiang Du

Frontiers of Medicine 2013, Volume 7, Issue 4,   Pages 506-509 doi: 10.1007/s11684-013-0294-y

Abstract:

This study aimed to investigate patient dose in diagnostic screen-film radiographic examinations in

Keywords： radiation dosage     radiology     radiation protection     radiography/statistics & numerical data    

HTML PDF Collect

Complex interplay between tumor microenvironment and cancer therapy

Minhong Shen, Yibin Kang

Frontiers of Medicine 2018, Volume 12, Issue 4,   Pages 426-439 doi: 10.1007/s11684-018-0663-7

Abstract:

Tumor microenvironment (TME) is comprised of cellular and non-cellular components that exist withinand around the tumor mass.Given the importance of TME in tumor progression and therapy resistance, strategies that remodel TME

Keywords： tumor microenvironment     therapy response     treatment resistance    

HTML PDF Collect

Immunosuppressive tumor microenvironment contributes to tumor progression in diffuse large B-cell lymphoma

Frontiers of Medicine 2023, Volume 17, Issue 4,   Pages 699-713 doi: 10.1007/s11684-022-0972-8

Abstract: However, the underlying mechanism of alterations in the tumor microenvironments resulting in CAR-T cellSingle-cell RNA sequencing results were obtained from core needle biopsy tumor samples collected fromM2-subtype macrophages were significantly involved in both in vivo and in vitro anti-tumorImmunosuppressive tumor microenvironments persisted before CAR-T cell therapy, during both cell expansionThus, our findings provided a clinical rationale for targeting tumor microenvironments and reprogramming

Keywords： anti-CD19 chimeric antigen receptor T     immunotherapy     diffuse large B cell lymphoma     tumor microenvironment     tumor-associated macrophage     metabolism    

HTML PDF Collect

Novel mutation c.1210-3C>G in with a poly-T tract of 5T affects mRNA splicing in a Chinese patient

Frontiers of Medicine 2022, Volume 16, Issue 1,   Pages 150-155 doi: 10.1007/s11684-021-0846-5

Abstract: To identify the potential pathogenic mutations in a Chinese patient with CF, we conducted Sanger sequencingon the genomic DNA of the patient and his parents and detected all 27 coding exons of CFTR andThe patient is a compound heterozygote of c.2909G>A, p.Gly970Asp in exon 18 and c.1210-3C>G in cisOverall, c.1210-3C>G, the newly identified pathogenic mutation in our patient, in combination with T5Moreover, this patient carries a p.Gly970Asp mutation, thus confirming the high-frequency of this mutation

Keywords： cystic fibrosis     CFTR     splicing mutation     minigene    

HTML PDF Collect

Innate immune checkpoint Siglec10 in cancers: mining of comprehensive omics data and validation in patient

Frontiers of Medicine 2022, Volume 16, Issue 4,   Pages 596-609 doi: 10.1007/s11684-021-0868-z

Abstract: checkpoints that inhibits the activation of immune cells through the interaction with its ligand CD24 on tumorIn 131 KIRC patients of our settings, Siglec10 was elevated in the tumor tissues of 83 (63.4%) patients

Keywords： innate immune checkpoint     Siglec10     kidney renal clear cell carcinoma    

HTML PDF Collect

Title Author Date Type Operation

Tumor-Specific CircRNA-Derived Antigen Peptide Identification for Hepatobiliary Tumors

Wenwen Wang, Lili Ma, Zheng Xing, Tinggan Yuan, Jinxia Bao, Yanjing Zhu, Xiaofang Zhao, Yan Zhao, Yali Zong, Yani Zhang, Siyun Shen, Xinyao Qiu, Shuai Yang, Hongyang Wang, Dong Gao, Peng Wang, Lei Chen

Journal Article

Patient-derived xenograft platform of OSCC: a renewable human bio-bank for preclinical cancer research

Shuyang Sun,Zhiyuan Zhang

Journal Article

Repurposed benzydamine targeting CDK2 suppresses the growth of esophageal squamous cell carcinoma

Journal Article

Prediction of Driver Gene Matching in Lung Cancer NOG/PDX Models Based on Artificial Intelligence

Yayi He, Haoyue Guo, Li Diao, Yu Chen, Junjie Zhu, Hiran C. Fernando, Diego Gonzalez Rivas, Hui Qi, Chunlei Dai, Xuzhen Tang, Jun Zhu, Jiawei Dai, Kan He, Dan Chan, Yang Yang

Journal Article

The value of radionuclide hepatobiliary scintigraphy in combination with determination of bilirubin from

Sheng-Xuan LIU, Zhi-Hua HUANG

Journal Article

Tumor-derived exosomes induce initial activation by exosomal CD19 antigen but impair the function of

Journal Article

Organoid Technology and Clinical Applications in Digestive System Cancer

Xiaofang Zhao, Youhai Jiang, Chunliang Liu, Minghui Hou, Hongyang Wang, Jing Fu

Journal Article

Arsenic trioxide induced rhabdomyolysis, a rare but severe side effect, in an APL patient: a case report

Haiyan He, Ran An, Jian Hou, Weijun Fu

Journal Article

Heterogeneity of the tumor immune microenvironment and clinical interventions

Journal Article

Proteins moonlighting in tumor metabolism and epigenetics

Lei Lv, Qunying Lei

Journal Article

An investigation on patient dose in screen-film diagnostic radiology in Lhasa City, Xizang Autonomous

Xiang Du

Journal Article

Complex interplay between tumor microenvironment and cancer therapy

Minhong Shen, Yibin Kang

Journal Article

Immunosuppressive tumor microenvironment contributes to tumor progression in diffuse large B-cell lymphoma

Journal Article

Novel mutation c.1210-3C>G in with a poly-T tract of 5T affects mRNA splicing in a Chinese patient

Journal Article

Innate immune checkpoint Siglec10 in cancers: mining of comprehensive omics data and validation in patient

Journal Article